Profitable Specialty Pharmaceuticals Company Investment Opportunity in Hyderabad, India
Research-based product development partner and medicine developer with 5 global clients seeks investment.
Premium Plan
| Established | 1-5 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 150 thousand |
| Run Rate Sales | USD 420 thousand |
| EBITDA Margin | 40 % |
| Industries | Specialty Pharmaceuticals |
| Locations | Hyderabad |
| Local Time | 8:34 AM Asia / Kolkata |
| Listed By | Management Member |
| Status | Moderately Active |
Partial Stake Sale
USD
350 thousand
for
20.0%
stake
(Native Currency: INR 30,000,000)
Reason: We have some developed assets for scaleup which immediately turn into sellable goods.
Looking for s...
View More
Includes physical assets worth
USD
700 thousand
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Workspace area
(51.8 KB)
ROC-Verification.pdf
(66.6 KB)
Business Overview
We are working with five clients.
We are a research-based product development partner to pharmaceutical companies.
Promoter experience: Promoter is a pharmaceutical professional with 18+ years of work experience (Formulation scientist) turned to healthcare entrepreneur.
In 3 years, business will reach USD 2 million revenue per year.
We signed up new clients this year and have already achieved INR 1 Cr for this year.
More clients are in the pipeline.
We generate almost equal revenue from fee for service model and in-house asset sale model.
We are a research-based product development partner to pharmaceutical companies.
Promoter experience: Promoter is a pharmaceutical professional with 18+ years of work experience (Formulation scientist) turned to healthcare entrepreneur.
In 3 years, business will reach USD 2 million revenue per year.
We signed up new clients this year and have already achieved INR 1 Cr for this year.
More clients are in the pipeline.
We generate almost equal revenue from fee for service model and in-house asset sale model.
Products & Services Overview
1. Fee for Service model - Standalone Analytical services and Product development services.2. In-house assets development for tec pack/dossier selling or out-licensing.
Pleiades will develop, manufacture, and out license its generics and complex generic medicines. such as niche product segments like anti-cancer, anti-cancer adjuvants, anti-coagulants, anti-diabetic, rare.
Disease, and critical care medicines for global markets.
Assets Overview
Tangible Assets:Analytical equipment: Rs 3,20,00,000.
Formulations equipment: Rs 2,40,00,000.
Intangible assets: Rs 7,00,00,000.
4 anti-diabetic and 1 anticoagulant for global market filing.
5 molecules for domestic and RoW market filing.
Facilities Overview
We have research and development facility built in 8,000 square feet area in IDA Jeedimetla, Hyderabad, India in a rented premises.
Capitalization Overview
Promoters raised INR 4 Cr by bootstrapping and INR 3.6 Cr by debt loan from bank. Total number of investors are two. Shareholding pattern is 51:49.
Recent Activity
-
Earlier than 15 daysHead Of Global Contract, Specialty Pharmaceuticals Manufacturer, Richmond, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Pharmaceuticals Manufacturing And Distribution, Welwyn Garden City, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Pharmacy, Hatfield, Individual Investor / Buyer connected with the Business
Tags:
Profitable Specialty Pharmaceuticals Company Investment Opportunity in Hyderabad, India
·Invest in Profitable Specialty Pharmaceuticals Company in Hyderabad, India
·Profitable Specialty Pharmaceuticals Company Investment Opportunity
·Invest in Profitable Specialty Pharmaceuticals Company
·Investment Opportunity in Hyderabad, India
·Invest in Hyderabad, India
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
25 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 124,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses